| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks | President and COO
1 company
Simon Barry J. serves as a Director at IBRX. Across recent SEC filings that breaks down to 0 buys and 30 sells. Those positions are worth an estimated $29.9M at current prices.
Historically, Simon Barry J.'s trades have earned a strong insider score of 79/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +76.6%.
The biggest single holding is IBRX (~$29.9M) as Director. The recent filings there lean toward selling, a net 1,424,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 130,000 | $18.05 | $2,346,604.00 | -3.9% | |
| Jul 21, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 130,000 | $15.53 | $2,019,328.89 | -3.9% | |
| Jul 8, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 39,950 | $13.14 | $524,759.23 | -1.2% | |
| Jun 30, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 9 | $13.00 | $117.00 | - | |
| Jun 23, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sale+OE | 200,041 | $10.56 | $2,112,950.19 | -5.9% | |
| May 27, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sell | 75,000 | $7.56 | $567,337.50 | -2.3% | |
| May 21, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sell | 36,932 | $5.52 | $203,698.45 | -1.1% | |
| May 11, 2020 | IBRX Immunitybio, Inc. | See Remarks | Sell | 28,068 | $5.50 | $154,508.73 | -0.8% | |
| Sep 8, 2016 | IBRX Immunitybio, Inc. | President and COO | Sell | 32,000 | $7.49 | $239,671.20 | -1.0% |